Loading...
盐酸埃克替尼治疗晚期复发非小细胞肺癌的临床疗效
BACKGROUND AND OBJECTIVE: Icotinib hydrochloride is the third single target EGFR-TKI used in clinical treatment of advanced non-small cell lung cancer (NSCLC). Clinical research reports on its efficacy and survival in patients with Recurrent Advanced NSCLC are still little.The aim of this study is t...
Na minha lista:
| Udgivet i: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
中国肺癌杂志编辑部
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000608/ https://ncbi.nlm.nih.gov/pubmed/23676980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2013.05.05 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|